INSERM UMR 1033, University of Lyon, Hôpital Edouard Herriot, Lyon, France.
Prosom, Lyon, France.
J Bone Miner Res. 2019 Sep;34(9):1562-1573. doi: 10.1002/jbmr.3746. Epub 2019 Jun 27.
In older men, low estrogen levels are associated with poor bone microarchitecture. Data on androgens are discordant. We studied the link between baseline sex steroid levels (total 17β -estradiol [17βE2], total testosterone [tT], calculated bioavailable 17βE2 [bio-17βE2], and apparent free testosterone concentration [AFTC]) and bone microarchitecture deterioration assessed prospectively in a 820 older men followed for 8 years. Bone microarchitecture was assessed by HR-pQCT at baseline, then after 4 and 8 years. At both the skeletal sites, the bone microarchitecture deterioration rate did not correlate with serum levels of tT and 17βE2. At the distal radius, cortical area (Ct.Ar) decreased more rapidly in the lowest versus the highest AFTC quartile. At the distal tibia, cortical thickness (Ct.Th) decreased and trabecular area (Tb.Ar) increased more rapidly in the highest versus the lowest AFTC quartile. At the tibia, bone mineral content (BMC), total volumetric bone mineral density (Tt.vBMD), Ct.Th, and Ct.Ar decreased, whereas Tb.Ar increased faster in the lowest versus the highest bio-17βE2 quartile. In men who had both AFTC and bio-17βE2 in the lowest quartile (high-risk group), distal radius cortical vBMD (Ct.vBMD) decreased more rapidly compared with men who had both hormones in the three upper quartiles (reference group). At the distal tibia, Tt.vBMD, Ct.Th, Ct.Ar, and Ct.vBMD decreased, whereas Tb.Ar increased more rapidly in the high-risk group versus the reference group. In men receiving androgen deprivation therapy (ADT) for prostate cancer, BMC, Tt.vBMD, Ct.Th, Ct.Ar, and Ct.vBMD decreased, whereas Tb.Ar increased more rapidly than in men not receiving ADT at both the skeletal sites. Thus, in older men followed up prospectively, low levels of bio-17βE2, and to a smaller extent AFTC, are associated with accelerated cortical bone deterioration. Cortical bone deterioration was strongly accelerated in men receiving ADT who had very low levels of all sex steroids. © 2019 American Society for Bone and Mineral Research.
在老年男性中,低雌激素水平与骨微结构不良有关。关于雄激素的数据存在不一致。我们研究了基线性激素水平(总 17β-雌二醇[17βE2]、总睾酮[tT]、计算的生物可利用 17βE2[bio-17βE2]和表观游离睾酮浓度[AFTC])与前瞻性评估的 820 名老年男性 8 年后骨微结构恶化之间的联系。骨微结构在基线时通过 HR-pQCT 进行评估,然后在 4 年后和 8 年后进行评估。在两个骨骼部位,骨微结构恶化率与血清 tT 和 17βE2 水平均不相关。在桡骨远端,皮质面积(Ct.Ar)在最低 AFTC 四分位数组比最高四分位数组下降更快。在胫骨远端,皮质厚度(Ct.Th)下降,而最高 AFTC 四分位数组比最低四分位数组的骨小梁面积(Tb.Ar)增加更快。在胫骨中,骨矿物质含量(BMC)、总容积骨矿物质密度(Tt.vBMD)、Ct.Th 和 Ct.Ar 下降,而最低 bio-17βE2 四分位数组的骨小梁面积(Tb.Ar)增加更快。在同时处于 AFTC 和 bio-17βE2 最低四分位数的男性中(高危组),与同时处于三个较高四分位数的男性相比(参考组),桡骨远端皮质骨 vBMD(Ct.vBMD)下降更快。在胫骨远端,Tt.vBMD、Ct.Th、Ct.Ar 和 Ct.vBMD 下降,而高危组比参考组的骨小梁面积(Tb.Ar)增加更快。在接受前列腺癌雄激素剥夺治疗(ADT)的男性中,BMC、Tt.vBMD、Ct.Th、Ct.Ar 和 Ct.vBMD 下降,而骨小梁面积(Tb.Ar)增加更快,这比未接受 ADT 的男性更快。因此,在前瞻性随访的老年男性中,生物 17βE2 水平较低,在较小程度上,AFTC 水平与皮质骨恶化加速有关。在接受 ADT 且所有性激素水平极低的男性中,皮质骨恶化速度大大加快。2019 年美国骨骼与矿物质研究协会。